FDA Approves Oral Wegovy: Breakthrough Weight Loss Pill Promises Results Without Injections
In a significant advancement for weight loss treatments, the FDA has recently approved an oral version of Wegovy, a popular weight-loss drug manufactured by Novo Nordisk. This groundbreaking pill, containing the active ingredient semaglutide, offers a convenient alternative to the original injectable formulation, allowing patients to manage their weight with a simple daily pill. With…